Endocrine fibroblast growth factors as regulators of metabolic homeostasis

BioFactors

Volumn 35, Issue 1, 2009, Pages 52-60

  Kurosu, Hiroshi ^a   Kuro O, Makoto ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

FGF19; FGF21; FGF23; Klotho

Indexed keywords

BILE ACID; FATTY ACID; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 23; GLUCOSE; KLOTHO PROTEIN; PHOSPHATE; VITAMIN D; BETA GLUCURONIDASE; CELL RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; FEEDBACK SYSTEM; GENE EXPRESSION; HOMEOSTASIS; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; METABOLIC REGULATION; OSTEOMALACIA; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TUMOR CALCINOSIS; VITAMIN D METABOLISM; WASTING SYNDROME; ANIMAL; BIOLOGICAL MODEL; ENDOCRINE SYSTEM; HUMAN; METABOLISM;

ANIMALS; ENDOCRINE SYSTEM; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; PHOSPHATES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, FIBROBLAST GROWTH FACTOR; VITAMIN D;

EID: 65549158690     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.12     Document Type: Review

References (79)

1. Itoh, N. and Ornitz, D. M. (2008) Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 237, 18-27.
2. Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., Yu, X., White, K. E., Inagaki, T., Kliewer, S. A., Yamamoto, M., Kurosu, H., Ogawa, Y., Kuro-o, M., Lanske, B., Razzaque, M. S., and Mohammadi, M. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428.
3. Harmer, N. J., Pellegrini, L., Chirgadze, D., Fernandez-Recio, J., and Blundell, T. L. (2004) The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 43, 629-640.
4. Mohammadi, M., Olsen, S. K., and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107-137.
5. Xie, M. H., Holcomb, I., Deuel, B., Dowd, P., Huang, A., Vagts, A., Foster, J., Liang, J., Brush, J., Gu, Q., Hillan, K., Goddard, A., and Gurney, A. L. (1999) FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11, 729-735.
6. Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., and Ornitz, D. M. (2006) Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694-15700.
7. Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R., and Lanske, B. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20, 720-722.
8. Razzaque, M. S. and Lanske, B. (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298-305.
9. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M. C., Moe, O. W., and Kuro-o, M. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120-6123.
10. Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., and Yamashita, T. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774.
11. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., and Kuro-o, M. (2007) βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104, 7432-7437.
12. Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., and Kuro-o, M. (2007) Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695.
13. Lin, B. C., Wang, M., Blackmore, C., and Desnoyers, L. R. (2007) Liverspecific activities of FGF19 require Klotho beta. J. Biol. Chem. 282, 27277-27284.
14. Kharitonenkov, A., Dunbar, J. D., Bina, H. A., Bright, S., Moyers, J. S., Zhang, C., Ding, L., Micanovic, R., Mehrbod, S. F., Knierman, M. D., Hale, J. E., Coskun, T., and Shanafelt, A. B. (2008) FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho. J. Cell Physiol. 215, 1-7.
15. Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., and Imamura, T. (2008) βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 22, 1006-1014.
16. Yamashita, T., Yoshioka, M., and Itoh, N. (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 277, 494-498.
17. The ADHR Consortium. (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348.
18. Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., and Yamashita, T. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. USA 98, 6500-6505.
19. The HYP Consortium. (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat. Genet. 11, 130-136.
20. Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., Rios, H., Drezner, M. K., Quarles, L. D., Bonewald, L. F., and White, K. E. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 38, 1310-1315.
21. Lorenz-Depiereux, B., Bastepe, M., Benet-Pages, A., Amyere, M., Wagenstaller, J., Muller-Barth, U., Badenhoop, K., Kaiser, S. M., Rittmaster, R. S., Shlossberg, A. H., Olivares, J. L., Loris, C., Ramos, F. J., Glorieux, F., Vikkula, M., Juppner, H., and Strom, T.M. (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet. 38, 1248-1250.
22. Beck, L., Soumounou, Y., Martel, J., Krishnamurthy, G., Gauthier, C., Goodyer, C. G., and Tenenhouse, H. S. (1997) Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in Xlinked hypophosphatemic mice. J. Clin. Invest. 99, 1200-1209.
23. Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., and Quarles, L. D. (2006) Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 291, E38-E49.
24. Sitara, D., Razzaque, M. S., St-Arnaud, R., Huang, W., Taguchi, T., Erben, R. G., and Lanske, B. (2006) Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am. J. Pathol. 169, 2161-2170.
25. Ye, L., MacDougall, M., Zhang, S., Xie, Y., Zhang, J., Li, Z., Lu, Y., Mishina, Y., and Feng, J. Q. (2004) Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J. Biol. Chem. 279, 19141-19148.
26. Garringer, H. J., Fisher, C., Larsson, T. E., Davis, S. I., Koller, D. L., Cullen, M. J., Draman, M. S., Conlon, N., Jain, A., Fedarko, N. S., Dasgupta, B., and White, K. E. (2006) The role of mutant UDP-N-acetyl-a- Dgalactosamine- polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J. Clin. Endocrinol. Metab. 91, 4037-4042.
27. Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pages, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T.M., and Clausen, H. (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370-18377.
28. Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., and Yamashita, T. (2004) FGF- 23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429-435.
29. Yu, X., Ibrahimi, O. A., Goetz, R., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., and White, K. E. (2005) Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146, 4647-4656.
30. Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., Iwasaki, H., Iida, A., Shiraki-Iida, T., Nishikawa, S., Nagai, R., and Nabeshima, Y. I. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51.
31. Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., Shimomura, I., Takayama, Y., Herz, J., Kahn, C. R., Rosenblatt, K. P., and Kuro-o, M. (2005) Suppression of aging in mice by the hormone Klotho. Science 309, 1829-1833.
32. Arking, D. E., Krebsova, A., Macek, M., Sr., Macek, M., Jr., Arking, A., Mian, I. S., Fried, L., Hamosh, A., Dey, S., McIntosh, I., and Dietz, H. C. (2002) Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. USA 99, 856-861.
33. Arking, D. E., Becker, D. M., Yanek, L. R., Fallin, D., Judge, D. P., Moy, T. F., Becker, L. C., and Dietz, H. C. (2003) KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 72, 1154-1161.
34. Arking, D. E., Atzmon, G., Arking, A., Barzilai, N., and Dietz, H. C. (2005) Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 96, 412-418.
35. Kawano, K., Ogata, N., Chiano, M., Molloy, H., Kleyn, P., Spector, T. D., Uchida, M., Hosoi, T., Suzuki, T., Orimo, H., Inoue, S., Nabeshima, Y., Nakamura, K., Kuro-o, M., and Kawaguchi, H. (2002) Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J. Bone Miner. Res. 17, 1744-1751.
36. Ogata, N., Matsumura, Y., Shiraki, M., Kawano, K., Koshizuka, Y., Hosoi, T., Nakamura, K., Kuro-o, M., and Kawaguchi, H. (2002) Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 31, 37-42.
37. Yamada, Y., Ando, F., Niino, N., and Shimokata, H. (2005) Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J. Mol. Med. 83, 50-57. (Pubitemid 40169496)
38. Tohyama, O., Imura, A., Iwano, A., Freund, J. N., Henrissat, B., Fujimori, T., and Nabeshima, Y. (2004) Klotho is a novel β-glucuronidase capable of hydrolyzing steroid β-glucuronides. J. Biol. Chem. 279, 9777-9784.
39. Chang, Q., Hoefs, S., van der Kemp, A. W., Topala, C. N., Bindels, R. J., and Hoenderop, J. G. (2005) The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490-493.
40. Cha, S. K., Ortega, B., Kurosu, H., Rosenblatt, K. P., Kuro-o, M., and Huang, C. L. (2008) Removal of sialic acid involving Klotho causes cellsurface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. USA 105, 9805-9810.
41. Imura, A., Tsuji, Y., Murata, M., Maeda, R., Kubota, K., Iwano, A., Obuse, C., Togashi, K., Tominaga, M., Kita, N., Tomiyama, K., Iijima, J., Nabeshima, Y., Fujioka, M., Asato, R., Tanaka, S., Kojima, K., Ito, J., Nozaki, K., Hashimoto, N., Ito, T., Nishio, T., Uchiyama, T., and Fujimori, T. (2007) a-Klotho as a regulator of calcium homeostasis. Science 316, 1615-1618.
42. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568.
43. Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149.
44. Baum, M., Schiavi, S., Dwarakanath, V., and Quigley, R. (2005) Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int. 68, 1148-1153.
45. Lanske, B. and Razzaque, M. S. (2007) Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr. Opin. Nephrol. Hypertens. 16, 311-318.
46. Liu, S., Gupta, A., and Quarles, L. D. (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr. Opin. Nephrol. Hypertens. 16, 329-335.
47. Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., and Silver, J. (2007) The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117, 4003-4008.
48. Ichikawa, S., Imel, E. A., Kreiter, M. L., Yu, X., Mackenzie, D. S., Sorenson, A. H., Goetz, R., Mohammadi, M., White, K. E., and Econs, M. J. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684-2691.
49. Brownstein, C. A., Adler, F., Nelson-Williams, C., Iijima, J., Li, P., Imura, A., Nabeshima, Y., Reyes-Mugica, M., Carpenter, T. O., and Lifton, R. P. (2008) A translocation causing increased a-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc. Natl. Acad. Sci. USA 105, 3455-3460.
50. Chen, C. D., Podvin, S., Gillespie, E., Leeman, S. E., and Abraham, C. R. (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc. Natl. Acad. Sci. USA 104, 19796-19801.
51. Kuro-o, M. (2008) Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol. Metab. 19, 239-245.
52. Fukumoto, S. (2008) Actions and mode of actions of FGF19 subfamily members. Endocr. J. 55, 23-31.
53. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., Gerard, R. D., Repa, J. J., Mangelsdorf, D. J., and Kliewer, S. A. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225.
54. Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., Suino-Powell, K., Xu, H. E., Richardson, J. A., Gerard, R. D., Mangelsdorf, D. J., and Kliewer, S. A. (2006) Identification of a hormonal basis for gallbladder filling. Nat. Med. 12, 1253-1255.
55. Sinha, J., Chen, F., Miloh, T., Burns, R. C., Yu, Z., and Shneider, B. L. (2008) β-Klotho and FGF 15/19 inhibit the apical sodium dependent bile acid transporter in enterocytes and cholangiocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G996-G1003.
56. Ito, S., Kinoshita, S., Shiraishi, N., Nakagawa, S., Sekine, S., Fujimori, T., and Nabeshima, Y. I. (2000) Molecular cloning and expression analyses of mouse bklotho, which encodes a novel Klotho family protein. Mech. Dev. 98, 115-119.
57. Ito, S., Fujimori, T., Furuya, A., Satoh, J., and Nabeshima, Y. (2005) Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho. J. Clin. Invest. 115, 2202-2208.
58. Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M., Deng, C. X., and McKeehan, W. L. (2000) Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275, 15482-15489.
59. Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., Veniant, M. M., Li, Y. S., Lindberg, R., Chen, J. L., Tian, H., and Li, Y. (2007) Co-receptor requirements for fibroblast growth factor-19 signaling. J. Biol. Chem. 282, 29069-29072.
60. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li, D. S., Mehrbod, F., Jaskunas, S. R., and Shanafelt, A. B. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635.
61. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., Elmquist, J. K., Gerard, R. D., Burgess, S. C., Hammer, R. E., Mangelsdorf, D. J., and Kliewer, S. A. (2007) Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425.
62. Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., and Maratos-Flier, E. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437.
63. Lundasen, T., Hunt, M. C., Nilsson, L. M., Sanyal, S., Angelin, B., Alexson, S. E., and Rudling, M. (2007) PPARa is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360, 437-440.
64. Arner, P., Pettersson, A., Mitchell, P. J., Dunbar, J. D., Kharitonenkov, A., and Ryden, M. (2008) FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Lett. 582, 1725-1730.
65. Moyers, J. S., Shiyanova, T. L., Mehrbod, F., Dunbar, J. D., Noblitt, T. W., Otto, K. A., Reifel-Miller, A., and Kharitonenkov, A. (2007) Molecular determinants of FGF-21 activity-synergy and cross-talk with PPAR c signaling. J. Cell Physiol. 210, 1-6.
66. Wang, H., Qiang, L., and Farmer, S. R. (2008) Identification of a domain within peroxisome proliferator-activated receptor c regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol. Cell Biol. 28, 188-200.
67. Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., and Kliewer, S. A. (2008) Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 8, 77-83.
68. Russell, S. J. and Kahn, C. R. (2007) Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 8, 681-691.
69. Wente, W., Efanov, A. M., Brenner, M., Kharitonenkov, A., Koster, A., Sandusky, G. E., Sewing, S., Treinies, I., Zitzer, H., and Gromada, J. (2006) Fibroblast growth factor-21 improves pancreatic β-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470-2478.
70. Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., and Stewart, T. A. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143, 1741-1747.
71. Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M., Williams, P. M., Soriano, R., Corpuz, R., Moffat, B., Vandlen, R., Simmons, L., Foster, J., Stephan, J. P., Tsai, S. P., and Stewart, T. A. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145, 2594-2603.
72. Bai, X. Y., Miao, D., Goltzman, D., and Karaplis, A. C. (2003) The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J. Biol. Chem. 278, 9843-9849.
73. Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., and Nabeshima, Y. (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393-2403.
74. Chiang, J. Y. (2004) Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40, 539-551.
75. Russell, D. W. (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137-174.
76. Lefebvre, P., Chinetti, G., Fruchart, J. C., and Staels, B. (2006) Sorting out the roles of PPARa in energy metabolism and vascular homeostasis. J. Clin. Invest. 116, 571-580.
77. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., and Wahli, W. (1999) Peroxisome proliferator-activated receptor a mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498.
78. Kersten, S., Desvergne, B., and Wahli, W. (2000) Roles of PPARs in health and disease. Nature 405, 421-424.
79. Moore, D. D. (2007) Sister act. Science 316, 1436-1438.